Skip to main
NHI

NHI Stock Forecast & Price Target

NHI Analyst Ratings

Based on 6 analyst ratings
Buy
Strong Buy 17%
Buy 50%
Hold 33%
Sell 0%
Strong Sell 0%

Bulls say

National Health Investors is a self-managed REIT with a strong focus on senior housing and medical facilities, generating the majority of its revenue from real estate leases and mortgages. With a diversified portfolio and a low-levered balance sheet, the company has an attractive well-covered dividend yield. While there may be some dependence on top operators, the company's decision to focus on long-term growth over short-term gain with its recent sale of marketable securities appears to be a good strategic move. However, patience may be required as the company works to rebuild its NOI and surpass pre-deal levels.

Bears say

National Health Investors is a fundamentally sound company with stable revenues derived from a diverse portfolio of senior housing and medical facilities. However, the recent disposition of the NHC portfolio and lower FFO estimates suggest short-term challenges for the company. The concentration of operators and potential for underperformance in rent reset and deferred rent collections pose risks, but the company's low-levered balance sheet and strong investment pipeline could support long-term growth.

NHI has been analyzed by 6 analysts, with a consensus rating of Buy. 17% of analysts recommend a Strong Buy, 50% recommend Buy, 33% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of National Health Investors and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About National Health Investors (NHI) Forecast

Analysts have given NHI a Buy based on their latest research and market trends.

According to 6 analysts, NHI has a Buy consensus rating as of Aug 29, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $83.67, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $83.67, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

National Health Investors (NHI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.